Leukotrienes and rhinitis

Clinical and Experimental Allergy Reviews

Volumn 1, Issue 2, 2001, Pages 160-162

  Israel, E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; LORATADINE; MONTELUKAST; PLACEBO; ZAFIRLUKAST;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HUMAN; NOSE CONGESTION; NOSE MUCUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PRURITUS; QUALITY OF LIFE; RHINITIS; RHINORRHEA; SNEEZING; TREATMENT OUTCOME;

EID: 0034891219     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2001.00031.x     Document Type: Conference Paper

References (11)

1. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells
2. Heterogeneity of metachromatic cells in human nose: Significance of mucosal mast cells
3. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans
4. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis
5. 4 in allergic rhinitis
6. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis
7. 4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children
8. The influence of 5-lipoxygenase inhibition in allergic rhinitis
9. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor
10. The leukotriene D4-receptor antagonist, ICI204, 219, relieves symptoms of acute seasonal allergic rhinitis
11. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial